Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

First pivotal trial of lisofylline completed

Jan. 27, 1998

Protein farnesyltransferase inhibitors patented by Pfizer for cancer

Jan. 27, 1998

Resistance modulators for use in cancer and malaria developed at Lilly

Jan. 27, 1998

Theratechnologies' novel cancer treatment granted additional patent protection

Jan. 26, 1998

Imidazoles for reversing MDR prepared at Ontogen

Jan. 26, 1998

Clinical results reported for Servier's MDR-reversing agent S-9788

Jan. 23, 1998

Ontogen describes novel MDR modulators

Jan. 23, 1998

Merck & Co. describes FPTase inhibitors with improved pharmacokinetics

Jan. 23, 1998

New telomerase inhibitors from Geron

Jan. 23, 1998

Princeton and Lilly collaborate on development of inhibitors of folate enzymes

Jan. 23, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...